Category: PersonnelSyndicate content

NuVasive names Lucier CEO

May 26, 2015 by Brad Perriello

NuVasive names chairman and interim CEO Gregory Lucier to be its new chief executive, replacing the ousted Alex Lukianov.

NuVasive names Lucier CEO

NuVasive Inc. (NSDQ:NUVA) said today that it promoted its interim chief executive to the full-time spot, naming chairman Gregory Lucier CEO.

Elekta sacks CEO Savander on 2014 sales plunge, shares plummet

May 13, 2015 by Brad Perriello

Elekta shares take a nosedive after the company badly misses expectations with its fiscal 2014 results, prompting the Swedish medtech giant to sack CEO Niklas Savander.

Elekta sacks CEO Savander on 2014 sales plunge, shares plummet

UPDATE: NuVasive CEO's ouster makes acquisition more likely

April 1, 2015 by Brad Perriello

NuVasive says it ousted 16-year CEO Alex Lukianov over violations of its expense and personnel policies, leading analysts to speculate that an acquisition is now more likely for the spinal implant maker.

NuVasive ousts CEO Lukianov over expense, personnel violations

UPDATED April 1, 2015, with analysts' comments, share performance.

In swan song, FDA chief Hamburg defends approval process

March 30, 2015 by MassDevice

Departing FDA commissioner Dr. Margaret Hamburg defends the agency's approvals process in her final speech on the job.

In swan song, FDA chief Hamburg defends approval process

(Reuters) — In her final speech after 6 years as commissioner of the FDA, Dr. Margaret Hamburg defended the agency's approval standards against critics seeking weaker regulatory standards.

MRI Interventions to shutter Memphis plant

March 20, 2015 by Brad Perriello

MRI Interventions says it plans to shutter its Memphis operation, laying off all workers there, as it consolidates in California; appoints ex-Pro-Dex honcho Harold Hurwitz as its new CFO.

MRI Interventions to shutter Memphis plant

MRI Interventions (OTC:MRIC) said it plans to shutter its plant in Memphis in May and lay off all the workers there as the consolidates in Irvine, Calif.

Pyott out after Actavis closes $70B Allergan buyout

March 18, 2015 by Mark Hollmer

Former Allergan CEO David Pyott will not get a seat on the board at Actavis after all, now that their $70 billion merger is done.

Pyott out after Actavis closes $70B Allergan buyout

Preferred Vendors

Admet
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.
Emergo Group, Inc.
Regulatory charts and consulting
Resonetics
Polymer Micromachining
Tegra Medical
Provides contract manufacturing and assembly services
Vistek Medical
Manufacturer of medical implants and components used for orthopedic, spinal, extremity, and trauma
Interface Catheter Solutions
Balloon Catheters
GW Plastics Inc.
Provides injection molding services
Phase 2 Medical Manufacturing, Inc
Provides design, development, manufacturing, packaging, shipping, and sterilization services.
STERIS Isomedix Services
Provides sterilization and validation services using gamma irradiation, ethylene oxide and steam sterilization technologies through 19 North American locations
SMC Ltd. (Scientific Molding Corp.)
Manufactures injection-molded, single-use disposable medical devices
AdvancedCath
Finished Guidewires, Catheters as well as extrusions, catheter shafts and medical balloons
CB Set: Concord Biomedical Sciences and Emerging Technologies
Provides research support for all phases of biomedical discovery and development research.